PXN and heart failure: As shown in Fig 1D–1F, by 72 hpf, 78.46% ± 6.05% of MO1-paxillin injected embryos developed progressive heart failure characterized by reduced ventricular systolic force, severely reduced blood flow, blood congestion at the cardiac inflow tract and pericardial edema (S1 and S2 Movies).